Cite
APA Citation
Escudero-Vilaplana, V., Collado-Borrell, R., De Castro, J., Insa, A., Martínez, A., Fernández, E., Sullivan, I., Flores, A., Arrabal, N., Carcedo, D., & Manzaneque, A. (2023). cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1. Journal of medical economics, 26, 445–453. http://access.bl.uk/ark:/81055/vdc_100181752794.0x000026